Revenue | ₹49.52Cr |
Net Profits | ₹-2.15Cr |
Net Profit Margins | -4.34% |
Oxygenta Pharmaceutical Ltd’s revenue jumped 358.09% since last year same period to ₹49.52Cr in the Q4 2024-2025. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 46.99% jump in its revenue since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit fell -126.81% since last year same period to ₹-2.15Cr in the Q4 2024-2025. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 45.29% jump in its net profits since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit margin fell -105.85% since last year same period to -4.34% in the Q4 2024-2025. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 62.78% jumped in its net profit margins since last 3-months.
The revenue for Oxygenta Pharmaceutical Ltd in the Q4 results 2024 was ₹49.52Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q4 results 2024 was ₹-2.15Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q4 results 2024 was -4.34%.
The revenue for Oxygenta Pharmaceutical Ltd in the Q4 results 2023 was ₹10.81Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q4 results 2023 was ₹8.02Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q4 results 2023 was 74.19%.